Do Sleep Supplements Help, and Which Ones Have Evidence?
Melatonin has the best case among the sleep supplements reviewed here, especially when your body clock runs late and sleep won't come until well past your target bedtime. Magnesium now has one encouraging trial behind it. Valerian, glycine and L-theanine rest on thinner or shakier evidence. For insomnia that keeps coming back, cognitive behavioral therapy for insomnia (CBT-I) is the treatment with evidence for lasting remission, and you can do it online. The right choice depends on whether your problem is timing, falling asleep, or insomnia that has settled in.
Melatonin has a clear role when the problem is timing
For general insomnia, melatonin's effect is small on average and varies across analyses. A 2022 analysis of adults with non-comorbid chronic insomnia found no significant benefit on objective measures. Most of these trials ran only a few weeks. Some people probably respond better than others, but the evidence doesn't reliably predict who will benefit, so a short personal trial may be reasonable when the formulation and timing fit your sleep problem.
Formulation matters too. Prolonged-release melatonin gave more consistent results in trials than fast-release versions, and the European insomnia guideline allows it for adults 55 and older for up to three months while recommending against fast-release melatonin for insomnia. In Europe, that prolonged-release product is a prescription medicine, and its results don't automatically carry over to whatever gummy is on a store shelf.
Melatonin's stronger case is for a body clock that runs late. Earlier circadian studies show that timing shapes the result, with dosing before the body's evening melatonin rise generally producing a larger clock advance than dosing near bedtime. Moving the clock earlier doesn't guarantee more sleep, though. A 2010 meta-analysis found that melatonin advanced sleep timing in adults with this delayed pattern without significantly changing total sleep time or wake-up time.
Magnesium looks promising, and the other options are harder to read
Magnesium has one encouraging result. In a 2025 randomized trial, 155 healthy adults who reported poor sleep took magnesium bisglycinate or placebo for four weeks. Insomnia severity scores fell by nearly 4 points with magnesium and about 2 with placebo, a gap the authors themselves called modest. People who reported eating less magnesium tended to improve more, but this came from a self-reported diet rating and doesn't establish low intake or a low blood level as a reliable predictor of response.
Later trials haven't built on it cleanly. An October trial pairing magnesium with L-theanine and apigenin for two weeks found no significant improvement in sleep disturbance over placebo, though a mixed formula tested that briefly can't establish the efficacy of any one ingredient. The 2025 VA/DoD insomnia guideline called the magnesium evidence insufficient and recommended weakly against melatonin and valerian for chronic insomnia, but its review ended in March 2024, before the bisglycinate trial was published.
The other popular options each carry a signal of benefit and a reason for caution.
| Supplement | What the studies suggest | What remains uncertain |
|---|---|---|
| Melatonin | Earlier sleep timing with a delayed body clock; modestly faster sleep onset in some insomnia analyses | Results vary by formulation and sleep problem; lasting insomnia remission isn't established |
| Magnesium | A modest improvement in insomnia symptoms with bisglycinate | Other findings are mixed; lasting benefit and reliable predictors of response remain unclear |
| Valerian | Some reviews found more people reported better sleep | Reviews disagree; many trials were small, its strong smell may have undermined blinding, and lab-measured benefits haven't been consistent |
| Glycine | Better self-reported sleep quality and less morning fatigue when taken at bedtime | Trials lasted a few nights in small groups, and none had a low risk of bias |
| L-theanine | A 2025 meta-analysis found better self-reported sleep quality and faster self-reported sleep onset | Much of the pooled evidence comes from mixed formulas; results for theanine alone are mixed |
The alternatives could help a particular person, but they lack dependable evidence for lasting recovery from chronic insomnia. If you searched for a vitamin that helps sleep, this body of evidence doesn't make a case for any specific one.
What the bottle can't promise
In the US, supplements aren't approved by the FDA for safety or effectiveness before they're sold; manufacturers are responsible for their own compliance. Labels can also be wrong. Australian regulators reported this year that testing of selected imported melatonin products found some with substantially more than the stated amount and one with none. That finding applies to the products tested, but it's a reason to favor products with third-party verification, such as USP Verified, which checks that contents match the label.
In trials, melatonin's side effects generally showed up about as often as with placebo. The ones reported, mainly daytime sleepiness, headache and dizziness, were uncommon, though they became more frequent at very high doses, and combining melatonin with other sedatives can add to impairment. Long-term safety evidence remains limited. Magnesium can cause diarrhea, nausea and cramps, and poor kidney function raises the risk of toxicity.
For insomnia that won't let go, the best evidence is behavioral
Chronic insomnia is a different problem from a slow start some nights, and the outcome that matters is getting better and staying better. A 2024 network meta-analysis estimated that about 41% of adults treated with CBT-I reached long-term remission, with a plausible range from about a third to about half. Starting with CBT-I also outperformed starting with the prescription sleep medications studied for lasting remission, and the American College of Physicians and European guidelines both put it first. The most helpful pieces include changing the thoughts that keep you awake, limiting time spent awake in bed, and keeping a consistent sleep window. In-person delivery showed the largest benefit in a component analysis, but digital and telehealth versions also work, which matters if no local therapist is available.
Direct adult trials comparing CBT-I with melatonin remain scarce, so that remission figure isn't evidence that therapy beats the supplement head to head. What it does show is that CBT-I has evidence for lasting recovery, while the melatonin reviews do not establish comparable long-term remission.
Longer independent trials of single ingredients, studies testing whether low magnesium intake predicts who benefits, and trials adding a supplement to CBT-I would sharpen these choices. For now, if your insomnia has persisted, starting CBT-I, in person or online, is the step with evidence for lasting improvement.